KRAS mutations are also observed in cholangiocarcinoma, uterine endometrial carcinoma, testicular germ cell tumors, and cervical squamous cell carcinoma.74 The three mutation subtypes (G12C, G12D, and G12V) are also differentially prevalent across tumor types (Fig. 2). The gene discussed is KRAS; the disease is neoplasm.